$2.63 Billion is the total value of Tekla Capital Management LLC's 222 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DHR | Danaher Corp. | $28,178,000 | +27.8% | 159,352 | 0.0% | 1.07% | +7.5% | |
| NBIX | Neurocrine Biosciences, Inc. | $25,150,000 | +41.0% | 206,150 | 0.0% | 0.96% | +18.6% | |
| SRPT | Sarepta Therapeutics, Inc. | $22,468,000 | +63.9% | 140,129 | 0.0% | 0.86% | +37.9% | |
| BDX | Becton, Dickinson and Co. | $18,604,000 | +4.1% | 77,754 | 0.0% | 0.71% | -12.4% | |
| CNC | Centene Corp. | $18,315,000 | +7.0% | 288,194 | 0.0% | 0.70% | -9.9% | |
| SNY | Sanofisponsored adr | $16,712,000 | +16.8% | 327,367 | 0.0% | 0.64% | -1.7% | |
| MYL | Mylan N.V.shares | $16,253,000 | +7.9% | 1,010,754 | 0.0% | 0.62% | -9.1% | |
| BGNE | BeiGene, Ltd.sponsored adr | $14,127,000 | +53.0% | 74,984 | 0.0% | 0.54% | +29.0% | |
| PRAH | PRA Health Sciences, Inc. | $13,962,000 | +17.2% | 143,508 | 0.0% | 0.53% | -1.5% | |
| IQV | IQVIA Holdings Inc. | $11,672,000 | +31.5% | 82,266 | 0.0% | 0.44% | +10.7% | |
| IONS | Ionis Pharmaceuticals, Inc. | $11,391,000 | +24.7% | 193,201 | 0.0% | 0.43% | +5.1% | |
| WELL | Welltower Inc. | $10,510,000 | +13.0% | 203,083 | 0.0% | 0.40% | -4.8% | |
| ARGX | argenx SEsponsored adr | $10,130,000 | +71.0% | 44,977 | 0.0% | 0.39% | +44.0% | |
| AGIO | Agios Pharmaceuticals, Inc. | $9,999,000 | +50.7% | 186,964 | 0.0% | 0.38% | +27.0% | |
| TEVA | Teva Pharmaceutical Industries Ltd.sponsored adr | $9,690,000 | +37.3% | 785,851 | 0.0% | 0.37% | +15.7% | |
| OHI | Omega Healthcare Investors, Inc. | $9,110,000 | +12.0% | 306,433 | 0.0% | 0.35% | -5.7% | |
| MRTX | Mirati Therapeutics, Inc. | $8,995,000 | +48.5% | 78,784 | 0.0% | 0.34% | +24.8% | |
| NVO | Novo Nordisk A/Ssponsored adr | $8,775,000 | +8.8% | 134,005 | 0.0% | 0.33% | -8.5% | |
| DOC | Physicians Realty Trust | $8,685,000 | +25.7% | 495,733 | 0.0% | 0.33% | +6.1% | |
| HCA | HCA Healthcare, Inc. | $8,137,000 | +8.0% | 83,833 | 0.0% | 0.31% | -8.8% | |
| FGEN | FibroGen, Inc. | $7,874,000 | +16.6% | 194,270 | 0.0% | 0.30% | -1.6% | |
| MPW | Medical Properties Trust, Inc. | $7,741,000 | +8.7% | 411,743 | 0.0% | 0.30% | -8.4% | |
| UTHR | United Therapeutics Corp.class b | $7,685,000 | +27.6% | 63,513 | 0.0% | 0.29% | +7.4% | |
| VTR | Ventas, Inc. | $7,621,000 | +36.7% | 208,108 | 0.0% | 0.29% | +15.1% | |
| RARE | Ultragenyx Pharmaceutical Inc. | $7,625,000 | +76.1% | 97,480 | 0.0% | 0.29% | +48.0% | |
| BCEL | Atreca, Inc. | $7,500,000 | +28.6% | 352,424 | 0.0% | 0.28% | +8.0% | |
| JAZZ | Jazz Pharmaceuticals plcshares | $7,443,000 | +10.6% | 67,456 | 0.0% | 0.28% | -6.9% | |
| SBRA | Sabra Health Care REIT, Inc. | $7,369,000 | +32.2% | 510,660 | 0.0% | 0.28% | +11.1% | |
| LTC | LTC Properties, Inc. | $6,867,000 | +21.9% | 182,293 | 0.0% | 0.26% | +2.4% | |
| SYNH | Syneos Health, Inc.class a | $6,291,000 | +47.8% | 108,001 | 0.0% | 0.24% | +24.5% | |
| TFX | Teleflex Inc. | $6,279,000 | +24.3% | 17,252 | 0.0% | 0.24% | +4.8% | |
| PTCT | PTC Therapeutics, Inc. | $6,131,000 | +13.7% | 120,827 | 0.0% | 0.23% | -4.5% | |
| NKTR | Nektar Therapeutics | $6,093,000 | +29.7% | 263,079 | 0.0% | 0.23% | +9.4% | |
| ZGNX | Zogenix, Inc. | $5,818,000 | +9.2% | 215,406 | 0.0% | 0.22% | -8.3% | |
| APLS | Apellis Pharmaceuticals, Inc. | $5,666,000 | +21.9% | 173,494 | 0.0% | 0.22% | +2.9% | |
| CRSP | CRISPR Therapeutics AGnamen akt | $5,602,000 | +73.3% | 76,222 | 0.0% | 0.21% | +45.9% | |
| CERN | Cerner Corp. | $5,587,000 | +8.8% | 81,500 | 0.0% | 0.21% | -8.2% | |
| BMYRT | Bristol-Myers Squibb Co.right | $5,276,000 | -5.8% | 1,473,710 | 0.0% | 0.20% | -20.6% | |
| BLUE | bluebird bio, Inc. | $5,139,000 | +32.8% | 84,194 | 0.0% | 0.20% | +12.0% | |
| STRO | Sutro Biopharma, Inc. | $4,976,000 | -23.9% | 641,268 | 0.0% | 0.19% | -36.1% | |
| MTD | Mettler-Toledo International Inc. | $4,932,000 | +16.7% | 6,123 | 0.0% | 0.19% | -1.6% | |
| XNCR | Xencor, Inc. | $4,801,000 | +8.4% | 148,231 | 0.0% | 0.18% | -8.5% | |
| TBPH | Theravance Biopharma, Inc. | $4,803,000 | -9.2% | 228,836 | 0.0% | 0.18% | -23.4% | |
| A | Agilent Technologies, Inc. | $4,642,000 | +23.4% | 52,525 | 0.0% | 0.18% | +4.1% | |
| ALLK | Allakos Inc. | $4,628,000 | +61.5% | 64,397 | 0.0% | 0.18% | +35.4% | |
| PIRS | Pieris Pharmaceuticals, Inc. | $4,493,000 | +36.0% | 1,449,269 | 0.0% | 0.17% | +14.8% | |
| ARDX | Ardelyx, Inc. | $4,205,000 | +21.7% | 607,698 | 0.0% | 0.16% | +2.6% | |
| PEAK | Healthpeak Properties, Inc. | $4,145,000 | +15.6% | 150,392 | 0.0% | 0.16% | -2.5% | |
| SAGE | Sage Therapeutics Inc | $4,000,000 | +44.8% | 96,211 | 0.0% | 0.15% | +21.6% | |
| XLRN | Acceleron Pharma Inc. | $3,869,000 | +6.0% | 40,606 | 0.0% | 0.15% | -10.9% | |
| EDIT | Editas Medicine, Inc. | $3,851,000 | +49.1% | 130,201 | 0.0% | 0.15% | +25.6% | |
| SNN | Smith & Nephew plcshares | $3,795,000 | +6.3% | 99,560 | 0.0% | 0.14% | -10.6% | |
| PKI | PerkinElmer, Inc. | $3,776,000 | +30.3% | 38,494 | 0.0% | 0.14% | +9.9% | |
| TAK | Takeda Pharmaceutical Company Ltd.sponsored ads | $3,768,000 | +18.1% | 210,146 | 0.0% | 0.14% | -0.7% | |
| DCPH | Deciphera Pharmaceuticals, Inc. | $3,665,000 | +45.0% | 61,370 | 0.0% | 0.14% | +21.9% | |
| Trillium Therapeutics Inc. | $3,625,000 | +100.3% | 448,049 | 0.0% | 0.14% | +68.3% | ||
| LGND | Ligand Pharmaceuticals Inc. | $3,421,000 | +53.8% | 30,590 | 0.0% | 0.13% | +28.7% | |
| RMD | ResMed Inc. | $3,424,000 | +30.4% | 17,831 | 0.0% | 0.13% | +9.2% | |
| EPZM | Epizyme, Inc. | $3,336,000 | +3.5% | 207,752 | 0.0% | 0.13% | -13.0% | |
| YMAB | Y-mAbs Therapeutics, Inc. | $3,307,000 | +65.5% | 76,548 | 0.0% | 0.13% | +40.0% | |
| ALKS | Alkermes plcshares | $3,297,000 | +34.6% | 169,930 | 0.0% | 0.12% | +12.6% | |
| ACHC | Acadia Healthcare Company, Inc. | $3,296,000 | +36.9% | 131,200 | 0.0% | 0.12% | +14.7% | |
| CRL | Charles River Laboratories International, Inc. | $3,220,000 | +38.1% | 18,467 | 0.0% | 0.12% | +17.1% | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $3,204,000 | +50.1% | 74,186 | 0.0% | 0.12% | +27.1% | |
| ZLAB | Zai Lab Ltd.adr | $3,082,000 | +59.5% | 37,523 | 0.0% | 0.12% | +34.5% | |
| HR | Healthcare Realty Trust Inc. | $3,047,000 | +4.9% | 104,024 | 0.0% | 0.12% | -11.5% | |
| OVID | Ovid Therapeutics Inc.sponsored adr | $2,747,000 | +147.3% | 372,733 | 0.0% | 0.10% | +110.0% | |
| ALGN | Align Technology, Inc. | $2,756,000 | +57.8% | 10,041 | 0.0% | 0.10% | +32.9% | |
| INSM | Insmed Inc. | $2,710,000 | +71.8% | 98,387 | 0.0% | 0.10% | +45.1% | |
| ANAB | AnaptysBio, Inc. | $2,642,000 | +58.1% | 118,261 | 0.0% | 0.10% | +32.9% | |
| AXSM | Axsome Therapeutics, Inc. | $2,599,000 | +39.9% | 31,591 | 0.0% | 0.10% | +17.9% | |
| PHG | Koninklijke Philips N.V.ny reg sh | $2,613,000 | +16.6% | 55,796 | 0.0% | 0.10% | -2.0% | |
| ITCI | Intra-Cellular Therapies, Inc. | $2,419,000 | +67.1% | 94,238 | 0.0% | 0.09% | +41.5% | |
| DGX | Quest Diagnostics Inc. | $2,396,000 | +41.9% | 21,025 | 0.0% | 0.09% | +19.7% | |
| NVAX | Novavax, Inc. | $2,380,000 | +513.4% | 28,550 | 0.0% | 0.09% | +405.6% | |
| BHC | Bausch Health Companies Inc. | $2,166,000 | +18.0% | 118,412 | 0.0% | 0.08% | -1.2% | |
| ESPR | Esperion Therapeutics, Inc. | $2,133,000 | +62.7% | 41,577 | 0.0% | 0.08% | +37.3% | |
| ALC | Alcon Inc.ordinary shares | $2,103,000 | +12.8% | 36,686 | 0.0% | 0.08% | -4.8% | |
| RVNC | Revance Therapeutics, Inc. | $2,096,000 | +65.0% | 85,840 | 0.0% | 0.08% | +40.4% | |
| PTLA | Portola Pharmaceuticals, Inc.sponsored adr | $1,965,000 | +152.2% | 109,246 | 0.0% | 0.08% | +114.3% | |
| GMRE | Global Medical REIT Inc. | $1,982,000 | +12.0% | 174,897 | 0.0% | 0.08% | -6.2% | |
| CLLS | Cellectissponsored adr | $1,961,000 | +93.6% | 110,147 | 0.0% | 0.08% | +63.0% | |
| HRTX | Heron Therapeutics, Inc. | $1,930,000 | +25.3% | 131,183 | 0.0% | 0.07% | +4.3% | |
| HALO | Halozyme Therapeutics, Inc. | $1,874,000 | +49.0% | 69,917 | 0.0% | 0.07% | +24.6% | |
| MYOK | MyoKardia, Inc. | $1,865,000 | +106.1% | 19,300 | 0.0% | 0.07% | +73.2% | |
| HTA | Healthcare Trust of America, Inc. | $1,874,000 | +9.2% | 70,662 | 0.0% | 0.07% | -9.0% | |
| HOLX | Hologic, Inc. | $1,856,000 | +62.4% | 32,564 | 0.0% | 0.07% | +36.5% | |
| ENDP | Endo International plcshares | $1,823,000 | -7.3% | 531,570 | 0.0% | 0.07% | -22.5% | |
| INGN | Inogen, Inc. | $1,826,000 | -31.2% | 51,406 | 0.0% | 0.07% | -42.5% | |
| MEDP | Medpace Holdings, Inc. | $1,755,000 | +26.7% | 18,871 | 0.0% | 0.07% | +6.3% | |
| THC | Tenet Healthcare Corp. | $1,752,000 | +25.8% | 96,736 | 0.0% | 0.07% | +6.3% | |
| STE | STERIS plcshares | $1,721,000 | +9.6% | 11,218 | 0.0% | 0.07% | -7.0% | |
| PACB | Pacific Biosciences of California, Inc. | $1,709,000 | +12.7% | 495,495 | 0.0% | 0.06% | -5.8% | |
| EVH | Evolent Health, Inc. | $1,645,000 | +31.2% | 231,027 | 0.0% | 0.06% | +10.5% | |
| DHC | Diversified Healthcare Trust | $1,583,000 | +21.9% | 357,720 | 0.0% | 0.06% | +1.7% | |
| MDGL | Madrigal Pharmaceuticals, Inc. | $1,511,000 | +69.6% | 13,340 | 0.0% | 0.06% | +45.0% | |
| AUPH | Aurinia Pharmaceuticals Inc. | $1,475,000 | +12.0% | 90,788 | 0.0% | 0.06% | -6.7% | |
| SGMO | Sangamo Therapeutics, Inc. | $1,343,000 | +40.8% | 149,835 | 0.0% | 0.05% | +18.6% | |
| WVE | WaVe Life Sciences Ltd.shares | $1,334,000 | +11.1% | 128,146 | 0.0% | 0.05% | -5.6% | |
| GLPG | Galapagos NVsponsored adr | $1,291,000 | +0.7% | 6,543 | 0.0% | 0.05% | -15.5% | |
| BBIO | BridgeBio Pharma, Inc. | $1,279,000 | +12.4% | 39,228 | 0.0% | 0.05% | -3.9% | |
| KOD | Kodiak Sciences Inc. | $1,253,000 | +13.5% | 23,153 | 0.0% | 0.05% | -4.0% | |
| VRNA | Verona Pharma plcsponsored adr | $1,182,000 | +13.3% | 253,179 | 0.0% | 0.04% | -4.3% | |
| ACIU | AC Immune SAshares | $1,156,000 | -2.6% | 171,813 | 0.0% | 0.04% | -18.5% | |
| NTLA | Intellia Therapeutics, Inc. | $1,157,000 | +71.9% | 55,050 | 0.0% | 0.04% | +46.7% | |
| XLV | Health Care Select Sector SPDR Fundsbi healthcare | $1,006,000 | +12.9% | 10,055 | 0.0% | 0.04% | -5.0% | |
| AXNX | Axonics Modulation Technologies, Inc. | $987,000 | +38.2% | 28,100 | 0.0% | 0.04% | +18.8% | |
| AERI | Aerie Pharmaceuticals, Inc. | $984,000 | +9.3% | 66,688 | 0.0% | 0.04% | -9.8% | |
| RUBY | Rubius Therapeutics, Inc. | $933,000 | +34.4% | 155,982 | 0.0% | 0.04% | +16.1% | |
| EIDX | Eidos Therapeutics, Inc. | $953,000 | -2.8% | 20,000 | 0.0% | 0.04% | -18.2% | |
| SNR | New Senior Investment Group Inc. | $928,000 | +41.5% | 256,398 | 0.0% | 0.04% | +16.7% | |
| UHT | Universal Health Realty Income Trustshares | $895,000 | -21.1% | 11,258 | 0.0% | 0.03% | -33.3% | |
| GRFS | Grifols, S.A.sponsored adr | $864,000 | -9.4% | 47,373 | 0.0% | 0.03% | -23.3% | |
| MIST | Milestone Pharmaceuticals Inc. | $806,000 | +105.6% | 213,310 | 0.0% | 0.03% | +72.2% | |
| RGNX | REGENXBIO Inc. | $799,000 | +13.7% | 21,700 | 0.0% | 0.03% | -6.2% | |
| IMGN | ImmunoGen, Inc. | $774,000 | +34.8% | 168,190 | 0.0% | 0.03% | +11.5% | |
| PBYI | Puma Biotechnology, Inc. | $744,000 | +23.6% | 71,340 | 0.0% | 0.03% | +3.7% | |
| CDTX | Cidara Therapeutics, Inc. | $720,000 | +48.8% | 195,256 | 0.0% | 0.03% | +22.7% | |
| CHCT | Community Healthcare Trust Inc. | $609,000 | +6.8% | 14,900 | 0.0% | 0.02% | -11.5% | |
| NHI | National Health Investors, Inc. | $610,000 | +22.7% | 10,038 | 0.0% | 0.02% | +4.5% | |
| MOR | MorphoSys AGsponsored ads | $614,000 | +29.0% | 19,390 | 0.0% | 0.02% | +4.5% | |
| MTEM | Molecular Templates, Inc. | $583,000 | +3.7% | 42,313 | 0.0% | 0.02% | -12.0% | |
| SPPI | Spectrum Pharmaceuticals, Inc. | $388,000 | +45.3% | 114,670 | 0.0% | 0.02% | +25.0% | |
| TPTX | Turning Point Therapeutics, Inc. | $367,000 | +44.5% | 5,677 | 0.0% | 0.01% | +27.3% | |
| CYH | Community Health Systems, Inc. | $354,000 | -9.9% | 117,735 | 0.0% | 0.01% | -27.8% | |
| CBAY | CymaBay Therapeutics, Inc. | $307,000 | +136.2% | 88,102 | 0.0% | 0.01% | +100.0% | |
| ARPO | Aerpio Pharmaceuticals, Inc. | $322,000 | +126.8% | 257,554 | 0.0% | 0.01% | +100.0% | |
| CLSD | Clearside Biomedical, Inc. | $311,000 | +10.7% | 165,330 | 0.0% | 0.01% | -7.7% | |
| FVE | Five Star Senior Living Inc. | $95,000 | +41.8% | 24,237 | 0.0% | 0.00% | +33.3% | |
| TTPH | Tetraphase Pharmaceuticals, Inc. | $108,000 | +96.4% | 42,965 | 0.0% | 0.00% | +100.0% | |
| CLDX | Celldex Therapeutics, Inc. | $92,000 | +666.7% | 7,053 | 0.0% | 0.00% | +300.0% | |
| MNKKQ | Mallinckrodt plcsponsored adr | $88,000 | +35.4% | 32,980 | 0.0% | 0.00% | 0.0% | |
| Bellicum Pharmaceuticals, Inc. | $45,000 | +60.7% | 6,000 | 0.0% | 0.00% | +100.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Gilead Sciences, Inc. | 41 | Q2 2023 | 12.4% |
| Amgen, Inc. | 41 | Q2 2023 | 5.8% |
| Biogen Inc. | 41 | Q2 2023 | 6.5% |
| Vertex Pharmaceuticals Incorporated | 41 | Q2 2023 | 5.3% |
| Regeneron Pharmaceuticals, Inc. | 41 | Q2 2023 | 9.1% |
| Illumina, Inc. | 41 | Q2 2023 | 3.4% |
| BioMarin Pharmaceutical Inc. | 41 | Q2 2023 | 2.9% |
| Teva Pharmaceutical Industries Ltd. | 41 | Q2 2023 | 3.2% |
| Neurocrine Biosciences, Inc. | 41 | Q2 2023 | 1.4% |
| McKesson Corporation | 41 | Q2 2023 | 2.2% |
View Tekla Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Rallybio Corp | January 23, 2023 | 1,727,067 | 4.6% |
| Zyla Life SciencesSold out | January 29, 2021 | 0 | 0.0% |
| ARCA biopharma, Inc. | January 24, 2020 | 36,068 | 2.3% |
| Verona Pharma plc | February 12, 2019 | 5,296,845 | 4.9% |
| Alliqua BioMedical, Inc. | February 12, 2018 | 165,000 | 3.3% |
| PIERIS PHARMACEUTICALS, INC. | February 12, 2018 | 1,962,380 | 4.4% |
| Intellipharmaceutics International Inc. | February 13, 2015 | 2,184,000 | 9.0% |
| HERON THERAPEUTICS, INC. /DE/ | February 14, 2014 | 20,598,613 | 4.2% |
| MEDWAVE INC | February 14, 2012 | 1,277,372 | 9.8% |
| MZT Holdings, Inc. | February 14, 2012 | 2,553,420 | 4.0% |
View Tekla Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-10 |
| 13F-HR | 2023-02-10 |
| SC 13G/A | 2023-01-23 |
| 13F-HR | 2022-11-01 |
| 13F-HR | 2022-07-29 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
| SC 13G | 2022-01-21 |
| 13F-HR | 2021-11-12 |
View Tekla Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.